Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa-Reference-Cited by-全球学者库

Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa

Published:2022-05-06 Issue:6593 Volume:376 Page:
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Pulliam Juliet R. C.¹^ORCID,van Schalkwyk Cari¹^ORCID,Govender Nevashan²^ORCID,von Gottberg Anne²³^ORCID,Cohen Cheryl²⁴^ORCID,Groome Michelle J.²³^ORCID,Dushoff Jonathan¹⁵^ORCID,Mlisana Koleka⁶⁷⁸^ORCID,Moultrie Harry²³^ORCID

Affiliation:

1. South African DSI-NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa.

2. National Institute for Communicable Diseases, Division of the National Health Laboratory Service, Johannesburg, South Africa.

3. School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

4. School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

5. McMaster University, Hamilton, Ontario, Canada.

6. National Health Laboratory Service, Johannesburg, South Africa.

7. School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.

8. Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.

Abstract

We provide two methods for monitoring reinfection trends in routine surveillance data to identify signatures of changes in reinfection risk and apply these approaches to data from South Africa’s severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic to date. Although we found no evidence of increased reinfection risk associated with circulation of the Beta (B.1.351) or Delta (B.1.617.2) variants, we did find clear, population-level evidence to suggest immune evasion by the Omicron (B.1.1.529) variant in previously infected individuals in South Africa. Reinfections occurring between 1 November 2021 and 31 January 2022 were detected in individuals infected in all three previous waves, and there has been an increase in the risk of having a third infection since mid-November 2021.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference33 articles.

1. Detection of a SARS-CoV-2 variant of concern in South Africa

2. GISAID: Global initiative on sharing all influenza data – from vision to reality

3. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

4. National Institute for Communicable Diseases “The daily COVID-19 effective reproductive number (R) in South Africa: Week 47 2021” (National Institute for Communicable Diseases 2021); https://www.nicd.ac.za/wp-content/uploads/2021/11/COVID-19-Effective-Reproductive-Number-in-South-Africa-week-47.pdf.

5. National Institute for Communicable Diseases “The daily COVID-19 effective reproductive number (R) in South Africa: Week 51 2021” (National Institute for Communicable Diseases 2021); https://www.nicd.ac.za/wp-content/uploads/2021/12/COVID-19-Effective-Reproductive-Number-in-South-Africa-week-51.pdf.

Cited by 555 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Divergent pathogenetic outcomes in BALB/c mice following Omicron subvariant infection;Virus Research;2024-03

2. Quantitative microfluidic assay to measure neutralizing and total antibodies for SARS-CoV-2;Sensors and Actuators B: Chemical;2024-03

3. Understanding SARS-CoV-2 spike glycoprotein clusters and their impact on immunity of the population from Rio Grande do Norte, Brazil;Infection, Genetics and Evolution;2024-03

4. Prevalence of SARS-CoV-2 variants in Prague wastewater determined by nanopore-based sequencing;Chemosphere;2024-03

5. Importance of Timely Sequencing, Tracking, and Surveillance of Emergent Variants;Accelerating Diagnostics in a Time of Crisis;2024-02-29